L2 Asset Management LLC Purchases New Position in Chemed Corporation $CHE

Posted by Brenda Bartman on Aug 25th, 2026

L2 Asset Management LLC acquired a new stake in Chemed Corporation (NYSE:CHE – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,911 shares of the company’s stock, valued at approximately $1,356,000.

Several other institutional investors have also added to or reduced their stakes in the business. Monetary Solutions Ltd purchased a new position in shares of Chemed in the fourth quarter worth $25,000. Los Angeles Capital Management LLC purchased a new stake in shares of Chemed during the fourth quarter valued at $26,000. BOK Financial Private Wealth Inc. purchased a new stake in shares of Chemed during the fourth quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Chemed in the 2nd quarter worth about $34,000. Finally, Versant Capital Management Inc increased its holdings in Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Price Performance

Shares of Chemed stock opened at $540.18 on Tuesday. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The stock’s fifty day moving average is $501.57 and its 200 day moving average is $447.26. The stock has a market cap of $7.06 billion, a P/E ratio of 27.13, a P/E/G ratio of 2.05 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same quarter in the previous year, the company posted $4.27 earnings per share. Chemed’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Monday, August 17th. This is a boost from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio (DPR) is currently 14.06%.

Insiders Place Their Bets

In related news, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the completion of the transaction, the executive vice president directly owned 13,912 shares in the company, valued at approximately $7,526,948.48. This represents a 6.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 6,537 shares of company stock valued at $3,406,014 in the last ninety days. Insiders own 3.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CHE shares. Royal Bank Of Canada lifted their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Chemed has a consensus rating of “Hold” and an average target price of $530.75.

Check Out Our Latest Stock Report on Chemed

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.